✦ LIBER ✦

Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End point reduction in hypertension (LIFE) study

✍ Scribed by Kristian Wachtell; Björn Hornestam; Mika Lehto; David J. Slotwiner; Eva Gerdts; Michael H. Olsen; Peter Aurup; Björn Dahlöf; Hans Ibsen; Stevo Julius; Sverre E. Kjeldsen; Lars H. Lindholm; Markku S. Nieminen; Jens Rokkedal; Richard B. Devereux

Book ID: 119264426
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 212 KB
Volume: 45
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2004.06.080

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiovascular morbidity and mortality i

Cardiovascular morbidity and mortality in the losartan intervention for end point reduction in hypertension study (LIFE): a randomised trial against atenolol

✍ B. Dahlof; B.R. Devereux; S.E. Kjeldsen 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Cardiovascular Morbidity and Mortality i

Cardiovascular Morbidity and Mortality in Hypertensive Patients With a History of Atrial Fibrillation

✍ K. Wachtell; B. Hornestam; M. Lehto 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 41 KB

The Effect of Losartan Versus Atenolol o

The Effect of Losartan Versus Atenolol on Cardiovascular Morbidity and Mortality in Patients With Hypertension Taking Aspirin: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study

✍ Eigil Fossum; Andreas Moan; Sverre E. Kjeldsen; Richard B. Devereux; Stevo Juliu 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 177 KB

Cardiovascular morbidity and mortality i

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

✍ Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beever 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 124 KB

Cardiovascular morbidity and mortality i

Cardiovascular morbidity and mortality in patients with diabetes in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

✍ L.H. Lindholm; H. Ibsen; B. Dahof 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Cardiovascular morbidity and mortality i

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

✍ Lars H Lindholm; Hans Ibsen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; U 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 110 KB